Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin gamma subfamily A, 5 (PCDHGA5) is a member of the protocadherin gamma gene cluster, which comprises neural cadherin-like cell adhesion molecules. These proteins feature six extracellular cadherin domains, a transmembrane domain, and a conserved cytoplasmic region, forming part of the molecular mechanisms underlying the specificity of neuronal cell-cell recognition and connectivity in the central nervous system. PCDHGA5 is mainly expressed in the brain and is thought to critically contribute to the establishment and maintenance of neuronal networks, functioning as a calcium-dependent cell adhesion molecule. While mutations in this gene are associated with neurodevelopmental disorders, its role has not been linked directly to drug targeting, biomarker use, or defined therapeutic safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin gamma subfamily A, 5 (PCDHGA5).